Cite
HARVARD Citation
Ouellet, D. et al. (2017). Advances and challenges of using CRISPR-Cas9 gene editing for treating Duchenne muscular dystrophy. Cell & gene therapy insights. 3 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ouellet, D. et al. (2017). Advances and challenges of using CRISPR-Cas9 gene editing for treating Duchenne muscular dystrophy. Cell & gene therapy insights. 3 (1), p. . [Online].